Keywords: توقف-C; APRI index; CDC; HALT-C; Liver cirrhosis; Severe obesity;
مقالات ISI توقف-C (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: توقف-C; Liver Cancer; Early Detection; Fibrosis; Survival; AFP; α-fetoprotein; BMI; body mass index; CI; confidence interval; CT; computed tomography; HALT-C; Hepatitis C Antiviral Long-term Treatment Against Cirrhosis; HCC; hepatocellular carcinoma; MRI; magnet
A Variant in PNPLA3 Associated With Fibrosis Progression but not Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
Keywords: توقف-C; HALT-C cohort; Viral hepatitis; Cirrhosis; Hepatitis C; Liver cancer; adiponutrin; CI; confidence interval; HALT-C; Hepatitis C Antiviral Long-Term Treatment against Cirrhosis; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; NASH; nonalcoholic stea
Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm
Keywords: توقف-C; Early Detection; Hepatitis C; Cirrhosis; Surveillance; AASLD; American Association for the Study of Liver Diseases; AFP; α-fetoprotein; AUC; area under the receiver operating characteristic curve; CT; computed tomography; FPR; false-positive rate; HALT-C
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
Keywords: توقف-C; HCV; hepatitis C virus; DAA; direct-acting antivirals; SVR; sustained virological response; MELD; model for end-stage liver disease; HCC; hepatocellular carcinoma; BCLC; Barcelona Clinic Liver Cancer group; LOD; limit of detection; EOT; end of treatment;
Research ArticleStatin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C
Keywords: توقف-C; HCV; hepatitis C virus; CHC; chronic hepatitis C; HCC; hepatocellular carcinoma; HMG CoA; 3-hydroxy-3-methylglutaryl-coenzyme A; HSCs; hepatic stellate cells; HALT-C; hepatitis C antiviral long-term treatment against cirrhosis; HAI; histology activity ind
Research ArticleStatin use and the risk of cirrhosis development in patients with hepatitis C virus infection
Keywords: توقف-C; HCV; hepatitis C virus; HCC; hepatocellular carcinoma; HALT-C; Hepatitis C Antiviral Long-term Treatment Against Cirrhosis; NHIRD; National Health Insurance Research Database; ICD-9 codes; International Classification of Diseases, Ninth Revision codes; DD
Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C
Keywords: توقف-C; Epidemiology; Viruses; Digestive System; Endocrinology; BMI; body mass index; CI; confidence interval; HALT-C; Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HOMA-IR; homeostasis model a
ReviewIs there sufficient evidence to recommend antiviral therapy in hepatitis C?
Keywords: توقف-C; HCV; hepatitis C virus; SVR; sustained virological response; HALT-C; Hepatitis C Antiviral Long-term Treatment Against Cirrhosis; HCC; hepatocellular carcinoma; RCT; randomized controlled trial; OR; odds ratio; CI; confidence interval; MELD; Model for End
Improving Hepatocellular Carcinoma Screening: Applying Lessons From Colorectal Cancer Screening
Keywords: توقف-C; Colon Cancer; Liver Cancer; Screening; Process of Care; Effectiveness; Health Services Research; CRC; colorectal cancer; CT; computed tomography; HALT-C; Hepatitis C Antiviral Long-term Treatment against Cirrhosis; HCC; hepatocellular carcinoma; HCV; hepa
Dietary Cholesterol Intake Is Associated With Progression of Liver Disease in Patients With Chronic Hepatitis C: Analysis of the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial
Keywords: توقف-C; Diet; Cholesterol; Hepatitis C; Cirrhosis; AHR; adjusted hazard ratio; BMI; body mass index; CI; confidence interval; CTP; Child-Turcotte-Pugh; FFQ; food frequency questionnaire; HALT-C; Hepatitis C Antiviral Long-term Treatment Against Cirrhosis; HCC
EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
Keywords: توقف-C; HCV; Hepatitis C virus; SNP; Single nucleotide polymorphism; PEG; Polyethylene glycol; HALT-C; Hepatitis C antiviral long-term treatment against cirrhosis; EPIC; Evaluation of PegIntron in control of hepatitis C cirrhosis; CT; Computed tomography; MR; Mag
EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
Keywords: توقف-C; HCV; Hepatitis C virus; SNP; Single nucleotide polymorphism; PEG; Polyethylene glycol; HALT-C; Hepatitis C antiviral long-term treatment against cirrhosis; EPIC; Evaluation of PegIntron in control of hepatitis C cirrhosis; CT; Computed tomography; MR; Mag
Mallory-Denk Bodies Are Associated With Outcomes and Histologic Features in Patients With Chronic Hepatitis C
Keywords: توقف-C; Keratins; Liver Disease; Intermediate Filaments; Cytoplasmic Inclusions; BMI; body mass index; CHC; chronic hepatitis C; HALT-C; hepatitis C antiviral Long-Term Treatment against Cirrhosis; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; MDBs; Mall
Research ArticleFibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 program
Keywords: توقف-C; CI; confidence interval; COPILOT; Colchicine versus PegIntron Long-Term; EPIC3; Evaluation of PegIntron in Control of Hepatitis C Cirrhosis; EVR; early virologic response; FT; FibroTest; HALT-C; Hepatitis C Antiviral Long-term Treatment against Cirrhosis;
Serum Fibrosis Marker Levels Decrease After Successful Antiviral Treatment in Chronic Hepatitis C Patients With Advanced Fibrosis
Keywords: توقف-C; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CHC; chronic hepatitis C; CI; confidence interval; HA; hyaluronic acid; HALT-C; hepatitis C antiviral long-term treatment against cirrhosis; HCV; hepatitis C virus; OR; odds ratio; PIIINP; am
Hepatitis C Virus: A Critical Appraisal of Approaches to Therapy
Keywords: توقف-C; AFP; alpha fetoprotein; AGA; American Gastroenterological Association; ALT; alanine aminotransferase; APRI; aspartate aminotransferase platelet ratio index; AUROC; area under the receiver operator characteristics; CI; confidence interval; CT; computed tom
Blunted Cytopenias and Weight Loss: New Correlates of Virologic Null Response to Re-treatment of Chronic Hepatitis C
Keywords: توقف-C; ALT; alanine aminotransferase; BMI; body mass index; HALT-C; Hepatitis C Antiviral Long-term Treatment against Cirrhosis; HCV; hepatitis C virus; SVR; sustained virologic response; HOMA; homeostasis model assessment; ULN; upper limit of normal;
Hepatic Steatosis in Hepatitis C: Comparison of Diabetic and Nondiabetic Patients in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial
Keywords: توقف-C; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BMI; body mass index; HALT-C; Hepatitis C Antiviral Long-term Treatment against Cirrhosis; HCV; hepatitis C virus; HOMA; homeostasis model assessment; IFN; interferon; IR; insulin resistance;
Roles of Iron and HFE Mutations on Severity and Response to Therapy During Retreatment of Advanced Chronic Hepatitis C
Keywords: توقف-C; HALT-C; Hepatitis C Anti-viral Long-term Treatment to prevent Cirrhosis; HC; hemochromatosis; HEIRS; Hemochromatosis and Iron Overload Screening; HOMA; homeostasis model assessment; NHANES; National Health and Nutrition Examination Survey;
Treatment of Hepatitis C in the Patient With Decompensated Cirrhosis
Keywords: توقف-C; CTP; Child-Turcotte-Pugh; HALT-C; Hepatitis C Antiviral Long-Term Treatment against Cirrhosis; HCV; hepatitis C virus; MELD; Model for End-Stage Liver Disease; SVR; sustained virologic response;
Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial
Keywords: توقف-C; Hepatitis C; Cognitive function; Neuropsychological testing; Hepatic fibrosis; BDI; beck depression inventory; BSI; brief symptom inventory; CHC; chronic hepatitis C; CIDI-LT; composite international diagnostic interview lifetime; HALT-C; hepatitis C anti